- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/861 - Adenoviral vectors
Patent holdings for IPC class C12N 15/861
Total number of patents in this class: 1665
10-year publication summary
|
47
|
71
|
115
|
88
|
108
|
119
|
130
|
114
|
102
|
70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4349 |
46 |
| The Regents of the University of California | 20108 |
31 |
| University of Massachusetts | 2232 |
29 |
| The University of North Carolina at Chapel Hill | 2057 |
29 |
| University of Florida Research Foundation, Inc. | 4053 |
27 |
| Janssen Vaccines & Prevention B.V. | 311 |
26 |
| Glaxosmithkline Biologicals S.A. | 1651 |
24 |
| GenVec, Inc. | 56 |
19 |
| The Salk Institute for Biological Studies | 447 |
19 |
| Voyager Therapeutics, Inc. | 266 |
19 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
16 |
| Mayo Foundation for Medical Education and Research | 3255 |
15 |
| Genethon | 253 |
14 |
| Oxford University Innovation Limited | 1555 |
14 |
| Washington University | 1625 |
14 |
| Beth Israel Deaconess Medical Center, Inc. | 859 |
12 |
| Epicentrx, Inc. | 91 |
12 |
| Janssen Biotech, Inc. | 1561 |
12 |
| Prevail Therapeutics, Inc. | 67 |
12 |
| Etubics Corporation | 40 |
11 |
| Other owners | 1264 |